KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ: KWESW) (TSXV: KWE) ("KWESST" or the "Company"), today announced the closing ...

KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ: KWESW) (TSXV: KWE) ("KWESST" or the "Company"), today announced that it has ...

The Company intends to use the proceeds to expand its business, repay outstanding indebtedness, and general corporate purposes, including working capital. ThinkEquity is acting as sole book-runner for ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, ...

MALVERN, PA - Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company focused on neurodegenerative diseases, has successfully closed its public offering, generating $21 million in gross ...

ThinkEquity acted as sole book-runner for the offering. Anthony, Linder & Cacomanolis, PLLC acted as legal counsel to NextNRG and Loeb & Loeb LLP acted as legal counsel to ThinkEquity in ...

Detailed price information for Annovis Bio Inc (ANVS-N) from The Globe and Mail including charting and trades.

All of the common stock and warrants are to be sold by the Company. ThinkEquity is acting as sole book-running manager for the offering. The Company expects to grant the underwriter a 45-day option to ...